首页|期刊导航|Journal of Biomedical Research|Generation of ST6GAL1/ST3GAL4 double-knockout Landrace pigs with reduced respiratory sialylated glycans and decreased influenza A virus susceptibility of derived fibroblasts in vitro

Generation of ST6GAL1/ST3GAL4 double-knockout Landrace pigs with reduced respiratory sialylated glycans and decreased influenza A virus susceptibility of derived fibroblasts in vitroOA

中文摘要

Pigs are important hosts in the ecology and cross-species transmission of influenza A viruses because their respiratory tract can contain both human-typeα2,6-linked and avian-typeα2,3-linked sialylated glycans.These glycan structures may allow pigs to support infection by influenza viruses of different host origins and can facilitate viral reassortment when coinfection occurs.Here,we used CRISPR/Cas9-mediated gene editing to disrupt the porcine ST6GAL1 and ST3GAL4 genes,which encode sialyltransferases involved in the biosynthesis ofα2,6-linked andα2,3-linked sialylated glycans,respectively.We generated ST6GAL1/ST3GAL4 double-knockout Landrace pigs and observed markedly reduced Sambucus nigra agglutinin(SNA)-and Maackia amurensis lectinⅡ(MALⅡ)-reactive sialylated glycans in the respiratory tract.Fibroblasts derived from the double-knockout pigs showed reduced susceptibility to H1N1,H3N2,and H9N2 influenza A virus infection in vitro.Transcriptomic analysis further revealed distinct gene-expression profiles between knockout and wild-type fibroblasts before and after H1N1 infection.Complementation of ST6GAL1 and ST3GAL4 restored sialylated glycan expression and increased viral susceptibility in cultured cells,supporting a causal contribution of these sialyltransferases to influenza A virus infection.Further in vivo challenge,transmission,safety,and independentfounder studies are required to determine whether this strategy can reduce influenza A virus infection or transmission in live pigs.

Lin Li;Shuyi Fang;Xiaoxue Li;Jingjing Liu;Wenhan Lu;Qinyuan Li;Jianghao Chang;Yilin Yuan;Bin Fang;Ying Wang;Yi Rao;Haiyuan Yang;Yifan Dai

Department of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaGcreatene(Suzhou)Biotechnology Co.,Ltd.,Suzhou Industrial Park,Suzhou,Jiangsu 215000,ChinaGcreatene(Suzhou)Biotechnology Co.,Ltd.,Suzhou Industrial Park,Suzhou,Jiangsu 215000,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaPeking-Tsinghua Center for Life Sciences,Peking University,Beijing 100871,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,ChinaDepartment of Medical Genetics,School of Basic Medical Science,Nanjing Medical University,Nanjing,Jiangsu 211166,China Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure,Nanjing Medical University,Nanjing,Jiangsu 211166,China

医药卫生

gene-edited pigsinfluenza A virusST6GAL1ST3GAL4

《Journal of Biomedical Research》 2026 (5)

P.505-520,16

supported by Gcreatene(Suzhou)Biotechnology Co.,Ltd.through a commissioned research grant to Nanjing Medical University(Grant No.2021KF0346 to L.L.)Jiangsu Province Key Laboratory of Biological Therapy for Organ Failure。

10.7555/JBR.39.20250300

评论